Therefore, despite great therapeutic progress achieved in the treatment of Crohn's disease and ulcerative colitis by targeting TNF with various types of antibodies, further detailed studies are necessary to better understand the pathomechanisms of tissue injury in IBD aimed at defining more specific therapeutic targets. Here, TNF is linked to inflammatory bowel disease.